生物3D打印技术
Search documents
研判2025!中国医用水凝胶行业产业链、市场规模及重点企业分析:前沿医疗赋能行业扩容,细胞治疗与组织工程应用成新引擎[图]
Chan Ye Xin Xi Wang· 2025-09-11 01:38
内容概况:2024年,中国医用水凝胶行业市场规模约为6.5亿元,同比增长4.84%。这一增长主要得益于 前沿医疗技术在中国医疗健康热点领域的逐步应用。在高值耗材市场,以水凝胶医用敷料为主的产品需 求持续攀升,市场容量逐年扩大。在再生医学领域,水凝胶的应用也在不断拓展,特别是在细胞与基因 治疗的药物递送以及组织工程技术的构建方面,其使用量显著增加,为行业的发展注入了新的动力。 相关上市企业:爱美客(300896)、键凯科技(688356)、华熙生物(688363)、昊海生科(688366) 相关企业:安徽皖维高新材料股份有限公司、北京键凯科技股份有限公司、浙江皇马科技股份有限公 司、华熙生物科技股份有限公司、长春吉原生物科技有限公司、山东海龙股份有限公司、江苏德纳化学 股份有限公司、安徽山河药用辅料股份有限公司、山东新华医疗器械股份有限公司 关键词:医用水凝胶、医用水凝胶市场规模、医用水凝胶行业现状、医用水凝胶发展趋势 一、行业概述 医用水凝胶是一种以亲水性聚合物为基础,通过物理或化学交联形成的三维网络结构材料,具有高吸水 性、生物相容性及湿润环境维持能力。它具有高吸水保水性、生物相容性好、柔韧等特点,并且可以 ...
诺普再生杨熙:打造生物3D打印平台为人类“打印”健康
Shang Hai Zheng Quan Bao· 2025-07-20 17:38
Core Viewpoint - The article highlights the ambition of Suzhou Nopu Regenerative Medicine Co., Ltd. to develop a biological 3D printing platform aimed at creating health solutions for humanity, allowing for the rapid production of body parts using a patient's own cells and biomaterials [2]. Group 1: Company Overview - Nopu Regenerative has established the first biological printing medical device production workshop in China and developed the OPUS biological printing technology platform, filling a gap in clinical applicability in the country [2]. - The company has obtained over 40 national patents and more than 10 software copyrights, participating in the establishment of multiple industry standards [2]. Group 2: Market Demand and Vision - The founder, Yang Xi, identified a significant demand for organ and tissue regeneration, noting that over 6 million people in China suffer from bone defects annually, with around 3 million needing skin repair and 4 million suffering from blindness [4]. - The company aims to create a platform that serves global health needs, emphasizing the importance of clinical application and commercialization in its technology development [4]. Group 3: Unique Business Model - Nopu Regenerative's business model focuses on creating a cross-disciplinary ecosystem by collaborating with top medical teams, establishing commercial barriers through professional recognition and reputation [5]. - The company emphasizes the development of human tissue substitutes to address supply shortages in organ transplantation and tissue engineering [5]. Group 4: Successful Collaborations - Nopu Regenerative has successfully collaborated with several top medical institutions, including Beijing Jishuitan Hospital and Shanghai Jiaotong University, to create customized artificial bones for patients, which has garnered significant attention in the professional field [6]. Group 5: Entrepreneurial Spirit - The founder emphasizes the importance of passion and commitment in entrepreneurship, fostering a culture of responsibility and innovation within the company [7]. - Yang Xi believes that gender does not determine success in business, and she aims to inspire more women to pursue their dreams in the biomedical field [7].